Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has been updated to reflect a new version of the study, with the addition of the study's registry identifier and collaborators, while significant details about the study's objectives and treatment protocols have been removed.SummaryDifference54%
- Check31 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check67 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.